VIVEbiotech participates in World Advanced Therapies and Regenerative Medicine Congress in London
The World Advanced Therapies and Regenerative Congress was held at the Business Design Centre in London from May 15 to 17.
This event is the most important European congress on advanced therapies with more than 1000 attendees and 300 speakers.
The agenda of the event focused on gene therapy, gene-edited cell therapies, stem cells, and regenerative medicine, and covered every phase of cell and gene therapy, as well as immunotherapy, from bioprocessing to translation to the clinic. Issues such as cost reimbursement, market access and product release to patients for these advanced therapies were discussed.
This congress was attended by the Business Development Director of VIVEbiotech, Dr. Natalia Elizalde, who had the opportunity to attend many presentations given by renowned people in the sector. In addition, Natalia had several meetings with potential customers or customers already in execution interested in VIVEbiotech’s lentiviral vector development and manufacturing services to be applied in human gene therapy trials.